MA for its US subsidiary AMSBIO LLC.

For more info on AMSBIO, its products, application solutions and customized custom made services please visit or contact the business on +1-800-987-0985 / +44-1235-828200 or email .. AMSBIO opens new UNITED STATES headquarters AMSBIO has announced the starting of a new UNITED STATES headquarters with executive administration facilities in Cambridge, MA for its US subsidiary – AMSBIO LLC. Related StoriesNew selection of purified, soluble immunoreceptors announced by AMSBIOGuide to organoid growthNew equipment to measure S-Adenosylmethionine and methylation index Founded in 1987, AMS Biotechnology is recognized today as a respected company adding to the acceleration of discovery through the provision of cutting-edge life research technology products and services for research and development in the medical, nutrition, cosmetics and energy industries.‘For sufferers with lung cancer, there are hardly any effective treatments available, so we investigated this unique compound which has activity against the AKT proteins and found it to be extremely successful,’ stated Krishna Menon, Ph.D., chief scientific officer of Cellceutix Company in Beverly, Mass. Menon and colleagues tested the compound, that your company calls Kevetrin, in two individual xenograft models: A549 and NCI-H1975, both of these multiple drug resistant. They examined 200 mg/kg of Kevetrin 3 x a day almost every other day against paclitaxel, one of the currently approved therapies for lung malignancy, 22 mg/kg four times each day every other day. Related StoriesOvarian cancer patients with a brief history of oral contraceptive use possess better outcomesMD Anderson study reveals why chemotherapy medications not effective for many pancreatic cancer patientsCornell biomedical engineers develop 'super organic killer cells' to destroy malignancy cells in lymph nodesIn the A549 model, Kevetrin considerably delayed tumor growth by 11 times in the first experiment and by 30 days in a do it again experiment.